Renakart Life Sciences Private Limited, a active private limited company, was established on 21 August 2015 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230KA2015PTC082430. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹6.44 M.
It upholds a compliant status. Its leadership includes Apeksha Sree Harsha (Director), Sangita Moreshawar Vaingankar (Director). Past directors included Apeksha Sree Harsha, Nimitha Mandya Lokeshbabu, Thimmaiah Chikavenkatappa Prasanna Kumar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.205/3, 60Ft Road, J.B.Kaval, Industrial Workers Layout, Shankarnagar Main Road, Nandini, Layout, Bangalore, Karnataka, 560096.
U24230KA2015PTC082430
082430
21 August 2015
₹7.50 M
₹6.44 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Renakart Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Apeksha Sree Harsha | Director | 14 Aug 2017 | Current |
| Sangita Moreshawar Vaingankar | Director | 15 May 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 23 Sep 2017 | Past |
| Pramod Abcsdd | Director | 04 Mar 2016 | Past |
| Pramod Abcsdd | Director | 18 May 2017 | Past |
| Pramod Abcsdd | Director | 23 Aug 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Renakart Life Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.39% increase. The company also saw a substantial improvement in profitability, with a 77.54% increase in profit. The company's net worth Soared by an impressive increase of 13.45%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Renakart Life Sciences had a public holding of 87.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Renakart Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Renakart Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renakart Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Renakart Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Renakart Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.
The activity Apeksha Sree Harsha was appointed as a Director was appointed as a Director on 14 Aug 2017 & has been associated with this company since 8 years 3 months . was completed.
Sangita Moreshawar Vaingankar was appointed as a Director was appointed as a Director on 15 May 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.
The activity Renakart Life Sciences Private Limited was registered on 21 Aug 2015 with Roc Bangalore & aged 10 years 3 months as per MCA records. was completed.
The CIN of Renakart Life Sciences Private Limited is U24230KA2015PTC082430.
Renakart Life Sciences Private Limited is headquartered at No.205/3, 60Ft Road, J.B.Kaval, Industrial Workers Layout, Shankarnagar Main Road, Nandini, Layout, Bangalore, Karnataka, 560096.
Renakart Life Sciences Private Limited was incorporated on 21 August 2015.
The current directors of Renakart Life Sciences Private Limited are
The primary industry of Renakart Life Sciences Private Limited is Trade.
Renakart Life Sciences Private Limited is unlisted.
The authorized capital of Renakart Life Sciences Private Limited is ₹7.50 M, and the paid-up capital is ₹6.44 M.
The compliance status of Renakart Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX